|
Infinium Pharmachem Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
399.39 Cr.
|
P/BV
|
6.32
|
Book Value (Rs.)
|
45.40
|
|
52 Week High/Low (Rs.)
|
393/178
|
FV/ML
|
10/500
|
P/E(X)
|
49.03
|
|
Bookclosure
|
13/09/2023
|
EPS (Rs.)
|
5.85
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR |
| FaceValue | 10.00 |
| | |
| | |
| INCOME | |
| Revenue From Operations [Net] | 155.71 |
| Total Operating Revenues | 155.71 |
| | |
| Other Income | 2.12 |
| Total Revenue | 157.83 |
| | |
| EXPENSES | |
| Cost Of Materials Consumed | 109.29 |
| Purchase Of Stock-In Trade | 14.33 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -6.02 |
| Employee Benefit Expenses | 7.43 |
| Finance Costs | 3.67 |
| Depreciation And Amortisation Expenses | 3.29 |
| Other Expenses | 14.26 |
| Total Expenses | 146.26 |
| | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 11.57 |
| | |
| Profit/Loss Before Tax | 11.57 |
| | |
| Tax Expenses-Continued Operations | |
| Current Tax | 3.73 |
| Total Tax Expenses | 3.73 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 7.84 |
| | |
| Profit/Loss From Continuing Operations | 7.84 |
| | |
| Profit/Loss For The Period | 7.84 |
| | |
| Minority Interest | 0.30 |
| Consolidated Profit/Loss After MI And Associates | 8.15 |
| | |
| OTHER INFORMATION | |
| | |
| EARNINGS PER SHARE | |
| Basic EPS (Rs.) | 5.60 |
| Diluted EPS (Rs.) | 5.60 |
